Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain Tumors

P. G. Aftimos, V. Diéras, S. Altintas, C. Anders, M. Arnedos, A. Gelderblom, P. Soetekouw, A. Jager, M. van Linde, D. Brandsma

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)i25
JournalAnnals of Oncology
Publication statusPublished - May 2014

Cite this